Mayne Pharma Group

Update in progress

MYX.AX (ASX)

Company RatingNeutral
SectorHealthcare
IndustryMedical Distribution

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on commercializing women’s health and dermatology products in Australia, New Zealand, the United States, Canada, Europe, Asia, and other regions. It operates in three segments—Women’s Health, Dermatology, and International—and provides oral drug delivery systems plus contract development and manufacturing for third parties. It also distributes dermatology, women’s health, and infectious disease products. Formerly Halcygen Pharmaceuticals Limited, it changed its name in 2010. The company was incorporated in 2005 and is based in Salisbury South, Australia.

Company score

Sentiment: 0.06; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.02; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.01; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.00; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.03; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive